Abstract
This study evaluated the risks and benefits of repeat hepatic cryotherapy for recurrent, unresectable hepatic metastases from colorectal carcinoma. Review of a prospective database identified 195 patients who underwent hepatic cryotherapy for metastatic colorectal carcinoma during a 7-year period. Of the 14 patients who underwent successful repeat cryotherapy for recurrences confined to the liver, 86% had Duke’s stage D colorectal carcinoma at initial diagnosis. The median age of the 14 patients was 58 years (range 41 to 77 years). The median number of hepatic metastases was three at the first cryotherapy and two at the second cryotherapy. At a median follow-up of 71 months, the mean survival times from original diagnosis, first cryotherapy, and second cryotherapy were 53,42, and 19 months, respectively. At the most recent follow-up, eight patients (57%) have died of their disease, four (29%) are alive with disease, and two (14%) have no evidence of disease. The mean interval between the first and second cryotherapies was 23 months. The complication rates after the first and second cryotherapies were 7% and 14%, respectively. One patient developed a wound dehiscence after the first cryotherapy. Following the second cryotherapy, one patient had a small bowel obstruction and another had a pleural effusion. There was no perioperative mortality. Repeat cryotherapy for recurrent, unresectable hepadc metastases from colorectal cancer is safe and improves survival. However, a prospective trial is needed to validate the efficacy of systemic therapy and to better define the indications for repeat hepatic cryotherapy.
Similar content being viewed by others
References
Pinson C, Wright J, Chapman W, Garrard C, Blair T, Sawyers J. Repeat hepatic surgery for colorectal cancer metastatic to the liver. Ann Surg 1996;223:765–776.
Fong Y, Blumgart L, Cohen A, Fortner J, Brennan M. Repeat hepatic resection for metastatic colorectal cancer. Ann Surg 1994;220:657–662.
Korpan N.. Hepatic cryosurgery for liver metastases. Longterm follow-up. Ann Surg 1997;225:193–201.
Dale P, Souza J, Brewer D. Cryosurgical ablation of unresectable hepatic metastases. J Surg Oncol 1998;68:242–245.
Stone M, Cady B, Jenkins R, McDermott W, Steele G. Surgical therapy for recurrent liver metastases from colorectal cancer. Arch Surg 1990;125:718–722.
Steele G, Osteen R, Wilson R, Brooks D, Mayer R, Zamcheck N, Ravikumar T. Patterns of failure after surgical cure of large liver tumors. AmJ Surg 1984;147:554–559.
Griffith K, Sugarbaker P, Chang A. Repeat hepatic resections for colorectal metastases. Surgery 1990;107:101–104.
Bozzetti F, Bignami P, Montalto F, Doci R, Gennari L. Repeated hepadc resection for recurrent metastases from colorectal cancer. Br J Surg 1992;79:146–148.
Kin T, Nakajima Y, Kanehiro H, Hisanage M, Ohyama T, Nishio K, Sho M, Nagao M, Nakano H. Repeat hepatectomy for recurrent colorectal metastases. World J Surg 1998;22:1087–1091.
Tandan VR, Harmantas A, Gallinger S. Long-term survival after hepatic cryosurgery versus surgical resection for metastatic colorectal carcinoma: A critical review of the literature. CanJ Surg 1997;40:175–181.
Seifert J, Morris D. Repeat hepatic cryotherapy for recurrent metastases from colorectal cancer. Surgery 1999;125:233–235.
Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin 2000;50:7–33.
Elias D, Lasser P, HoangJ, Leclere J, Debaene B, Bognel C, Spencer A, Rougier P. Repeat hepatectomy for cancer. Br J Surg 1993;80:1557–1562.
Lange J, Leese T, Castaing D, Bismuth H. Repeat hepatectomy for recurrent malignant tumors of the liver. Surg Gynecol Obstet 1989;169:119–126.
Former J. Recurrence of colorectal cancer after hepatic resection. AmJ Surg 1988;155:378–382.
Adson M. Resection of liver metastases—when is it worth while? World J Surg 1987; ll:5ll-520.
Jaffe B, Donegan W, Watson F, Spratt J. Factors influencing survival in paGents with untreated hepatic metastases. Surg Gynecol Obstet 1968; 127:1–11.
Wood C, Gillis C. Blumgart L. A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncol 1976;2:285–288.
Seifert J, Morris D. Prognostic factors after cryotherapy for hepatic metastases from colorectal cancer. Ann Surg 1998;228:201–208.
Kemeny N, Daly J, Reichman B, Geller N, Botet J, Oderman P Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial. Ann Intern Med 1987; 107:459–465.
Patt Y, Mavligit G. Arterial chemotherapy in the management of colorectal cancer. An overview. Semin Oncol 1991;18:478–490.
Weaver M, Ashton J, Zemel R. Treatment of colorectal liver metastases by cryotherapy. Semin Surg Oncol 1998;14:163–170.
Rossi S, Di Stasi M, Buscarini E, Cavanna L, Quaretti P, Squassante E, Garbagnati F, Buscarini L. Percutaneous radiofrequency interstitial thermal ablation in the treatment of small hepatocellular carcinoma. Cancer J Sci Am 1995; 1:73–81.
Siperstein A, Rogers S, Hansen P, Gitomirsky A. Laparoscopic thermal ablation of hepatic neuroendocrine metastases. Surgery 1997;122:1147–1155.
Curley S, Izzo F, Delrio P, Ellis L, Granchi J, Vallone P, Fiore F, Pignata S, Daniele B, Cremona F. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies. Ann Surg 1999;230:1–8.
Bilchik A, Rose D, Allegra D, Bostick P, Hsueh E, Morton D. Radiofrequency ablation: A minimally invasive technique with multiple applications. Cancer J Sci Am 1999;5:356–361.
Bilchik A, Wood T, Allegra D, Tsioulias G, Chung M, Rose D, Ramming K, Morton D. Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms—a proposed algorithm. Arch Surg 2000;135:657–664.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported in part by grant T32 CA 09689 from the National Cancer Institute and by funding from the Rogovin-Davidow Foundation, Los Angeles, Calif.
Rights and permissions
About this article
Cite this article
Chung, M.H., Ye, W., Ramming, K.P. et al. Repeat hepatic cryotherapy for metastatic colorectal cancer. J Gastrointest Surg 5, 287–293 (2001). https://doi.org/10.1016/S1091-255X(01)80050-0
Issue Date:
DOI: https://doi.org/10.1016/S1091-255X(01)80050-0